Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Published:2014-06 Issue:6 Volume:20 Page:776-780
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nishihori Taiga^ORCID,Perkins Janelle,Mishra Asmita,Komrokji Rami,Kim Jongphil,Kharfan-Dabaja Mohamed A.,Perez Lia,Lancet Jeffrey,Fernandez Hugo,List Alan,Anasetti Claudio,Field Teresa

Funder

Celgene

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. Myelodysplastic syndromes;Nimer;Blood,2008

2. Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B;Silverman;J Clin Oncol,2006

3. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

4. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome;Cutler;Blood,2004

5. Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection;Issa;Nature Clin Pract Oncol,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial;The Lancet Haematology;2023-11

2. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report;International Journal of Rheumatic Diseases;2023-09-28

3. Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndrome;Best Practice & Research Clinical Haematology;2021-12

4. EV/1-Positive Leukemias and Myelodysplastic Syndromes: Theoretical and Clinical Aspects (Literature Review);Clinical oncohematology;2021

5. Atypical Chronic Myeloid Leukemia: Where Are We Now?;International Journal of Molecular Sciences;2020-09-18